why choose us

First received: December 09, 2022

Clinical Trial: Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms

Study Status: Completed

Recruit Status: RECRUITING

Condition: Myeloid Neoplasm

Study Type: INTERVENTIONAL


Official Title: A Prospective, Multicenter, Single-Arm Pilot Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms

Brief Summary: The purpose of this study is to learn the effects of treatment with an investigational drug, CPX-351 in patients with secondary myeloid neoplasms (SMNs).

Read more